High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$15.7M
$15,705,142
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-10 | $2,076,532Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $1,342,909Large | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $1,246,235Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Other
2026-03-10
$1,502,952Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Other
|
2026-03-10 | $1,502,952Large | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
2026-03-10
$1,599,963Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
|
2026-03-10 | $1,599,963Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -57.9%
2026-03-10
$1,227,362Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -57.9%
|
2026-03-10 | $1,227,362Large | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Other
2026-03-10
$162,176
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Other
|
2026-03-10 | $162,176 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
2026-03-09
$763,662
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
|
2026-03-09 | $763,662 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Monia Brett P
• CEO
10b5-1 SellΔOwn -32.5%
2026-03-09
$8,850,642Whale
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 SellΔOwn -32.5%
|
2026-03-09 | $8,850,642Whale | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $4,477,181Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $2,485,652Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $547,087 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $127,282 | S | Form 4 |